Continued Access to DRV/Rtv in HIV-1 Infected Children and Adolescents (Rollover Patients From C212, C228, C230).
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 21 Aug 2017
At a glance
- Drugs Darunavir (Primary) ; Ritonavir; Ritonavir
- Indications HIV-1 infections
- Focus Adverse reactions; Therapeutic Use
- Sponsors Janssen R&D Ireland
- 17 Aug 2017 Planned End Date changed from 31 Aug 2017 to 31 Oct 2017.
- 17 Aug 2017 Planned primary completion date changed from 30 Jun 2017 to 31 Oct 2017.
- 24 May 2017 Planned End Date changed from 31 Jul 2017 to 31 Aug 2017.